Are you getting the best rate from your broker?
Compare your broker's rates now to find out if you can save money

Choose your broker below
Welcome to MutualFunds.com. Please help us personalize your experience.

Select the one that best describes you
ALERT

An Introduction to Drawdown Risk

Mutualfunds logo

PHLAX Prudential Jennison Health Sciences A

  • Fund
  • PHLAX
  • Price as of: Jun 27, 2017
  • $43.85
  • - $1.17
  • - 2.60%
  • Category
  • Health & Biotech Equities

PHLAX - Profile

Vitals

  • YTD Return 22.2%
  • 3 Yr Annualized Return 9.9%
  • 5 Yr Annualized Return 18.1%
  • Net Assets $2.12 B
  • Holdings in Top 10 42.0%

52 WEEK LOW AND HIGH

$43.85
$33.78
$45.31

Expenses

OPERATING RELATED FEES

  • Expense Ratio 1.17%

SALES FEES

  • Front Load 5.50%
  • Deferred Load N/A

BROKERAGE FEES

  • Turnover 25.00%

TRADING FEES

  • Max Redemption Fee N/A

Min Investment

Closed to new investors as of 2012-06-29

STANDARD (TAXABLE)

$2,500

IRA

$1,000

Investment Themes

CATEGORY

Health & Biotech Equities
  • Fund Type Open End Mutual Fund
  • Investment Style Health

Distributions

  • YTD Total Return 22.2%
  • 3 Yr Annualized Total Return 7.8%
  • 5 Yr Annualized Total Return 16.8%
  • Capital Gain Distribution Frequency Annually
  • Net Income Ratio -0.48%
DIVIDENDS
  • Dividend Yield N/A
  • Dividend Distribution Frequency Semi-Annually

Fund Details

  • Legal Name Prudential Jennison Health Sciences Fund
  • Fund Family Name PGIM Investments
  • Inception Date Jun 30, 1999
  • Shares Outstanding N/A
  • Share Class A
  • Currency USD
  • Domiciled Country United States
  • Manager David Chan

Fund Description

The Prudential Jennison Health Sciences Fund Class A (PHLAX) is an actively managed fund that focuses on the health care sector of the world’s equity markets. PHLAX can own drug, health care, medicine, medical devices, and biotechnology stocks and can invest in any market-cap size. The fund uses various fundamental analyses to uncover the best growth stocks within the health care sector.

Even with its low costs, PHLAX’s focus on riskier segments of the equity markets makes the fund a satellite position only within a broader equity portfolio. The fund is managed by Jennison Associates LLC.

PHLAX - Performance

Return Ranking - Trailing

Period PHLAX Return Category Return Low Category Return High Rank in Category (%) Quintile
YTD 22.2% -14.9% 29.3% 5.36% 1
1 Yr 12.1% -14.8% 30.4% 22.52% 2
3 Yr 9.9% * -7.5% 18.5% 38.89% 2
5 Yr 18.1% * 9.3% 21.9% 39.81% 2
10 Yr 13.3% * 6.1% 14.6% 11.11% 1

* Annualized


Return Ranking - Calendar

Period PHLAX Return Category Return Low Category Return High Rank in Category (%) Quintile
2016 -17.7% -29.8% 2.6% 66.36% 4
2015 -8.5% -20.4% 14.5% 81.82% 5
2014 18.0% -5.8% 33.7% 40.91% 3
2013 43.8% -2.6% 65.2% 38.53% 2
2012 11.5% -5.3% 36.5% 58.25% 3

Total Return Ranking - Trailing

Period PHLAX Return Category Return Low Category Return High Rank in Category (%) Quintile
YTD 22.2% -14.9% 29.3% 5.41% 1
1 Yr 5.9% -18.3% 28.4% 56.36% 3
3 Yr 7.8% * -14.2% 18.5% 52.78% 3
5 Yr 16.8% * 9.1% 21.9% 54.37% 3
10 Yr 12.6% * 6.1% 14.6% 14.14% 1

* Annualized


Total Return Ranking - Calendar

Period PHLAX Return Category Return Low Category Return High Rank in Category (%) Quintile
2016 -17.7% -25.1% 6.3% 68.81% 4
2015 5.6% -16.6% 39.1% 70.64% 4
2014 52.2% -5.8% 100.0% 3.67% 1
2013 133.8% -5.1% 398.7% 6.48% 1
2012 119.0% -2.6% 475.8% 6.00% 1

NAV & Total Return History

PHLAX - Holdings

Filings data as of: May 31, 2017

Concentration Analysis

PHLAX Category Low Category High PHLAX % Rank Quintile
Net Assets 2.12 B 20.4 M 46.9 B 12.50% 2
Number of Holdings 72 32 355 19.64% 4
Net Assets in Top 10 890 M 9.25 M 20.1 B 12.50% 2
Weighting of Top 10 42.0% 19.5% 74.0% 21.43% 3

Top 10 Holdings

  1. Biomarin Pharmaceutical Inc 6.06%
  2. Celgene Corp 4.90%
  3. Allergan PLC 4.59%
  4. UnitedHealth Group Inc 6.14%
  5. Incyte Corp 4.27%
  6. Aerie Pharmaceuticals Inc 3.33%
  7. Humana Inc 3.90%
  8. AstraZeneca PLC ADR 3.06%
  9. Cigna Corp 2.97%
  10. Illumina Inc 2.80%

Asset Allocation

Weighting Category Low Category High PHLAX % Rank Quintile
Stocks
95.72% 88.73% 100.89% 28.57% 5
Cash
2.78% 0.00% 12.07% 11.61% 2
Other
1.51% -11.71% 2.70% 3.57% 1
Preferred Stocks
0.00% 0.00% 0.71% 6.25% 3
Convertible Bonds
0.00% 0.00% 0.49% 3.57% 3
Bonds
0.00% 0.00% 2.91% 4.46% 3

Stock Sector Breakdown

Weighting Category Low Category High PHLAX % Rank Quintile
Healthcare
95.58% 11.52% 99.64% 14.29% 2
Technology
0.13% 0.00% 64.38% 24.11% 4
Utilities
0.00% 0.00% 1.11% 1.79% 2
Real Estate
0.00% 0.00% 1.50% 2.68% 2
Industrials
0.00% 0.00% 8.05% 10.71% 3
Financial Services
0.00% 0.00% 5.16% 5.36% 3
Energy
0.00% 0.00% 0.00% 0.89% 2
Communication Services
0.00% 0.00% 0.00% 0.89% 2
Consumer Defense
0.00% 0.00% 2.14% 12.50% 3
Consumer Cyclical
0.00% 0.00% 5.10% 7.14% 3
Basic Materials
0.00% 0.00% 1.96% 4.46% 3

Stock Geographic Breakdown

Weighting Category Low Category High PHLAX % Rank Quintile
US
90.52% 62.83% 99.64% 14.29% 2
Non US
5.20% 0.00% 37.17% 24.11% 4

PHLAX - Expenses

Operational Fees

PHLAX Fees (% of AUM) Category Low Category High Rank in Category (%) Quintile
Expense Ratio 1.17% 0.10% 4.31% 46.43% 2
Management Fee 0.72% 0.09% 1.25% 10.71% 3
12b-1 Fee 0.30% 0.00% 1.00% 7.59% 3
Administrative Fee N/A 0.01% 0.40% N/A N/A

Sales Fees

PHLAX Fees (% of AUM) Category Low Category High PHLAX Rank Quintile
Front Load 5.50% 3.50% 5.75% 7.69% 2
Deferred Load N/A 1.00% 5.00% N/A N/A

Trading Fees

PHLAX Fees (% of AUM) Category Low Category High PHLAX Rank Quintile
Max Redemption Fee N/A 0.75% 2.00% N/A N/A

Turnover Related Fees

Turnover provides investors a proxy for the trading fees incurred by mutual fund managers who frequently adjust position allocations. Higher turnover means higher trading fees.

PHLAX Fees (% of AUM) Category Low Category High PHLAX Rank Quintile
Turnover 25.00% 0.00% 699.00% 23.21% 2

PHLAX - Distributions

Dividend Yield Analysis

PHLAX Category Low Category High PHLAX % Rank Quintile
Dividend Yield N/A 0.01% 0.94% N/A N/A

Dividend Distribution Analysis

PHLAX Category Low Category High Category Mode
Dividend Distribution Frequency Semi-Annually Annually Quarterly Annually

Dividend Payout History


Net Income Ratio Analysis

PHLAX Category Low Category High PHLAX % Rank Quintile
Net Income Ratio -0.48% -2.22% 1.40% 40.18% 3

Capital Gain Distribution Analysis

PHLAX Category Low Category High Capital Mode
Capital Gain Distribution Frequency Annually Annually Semi-Annually Annually

PHLAX - Managers

David Chan

Manager

Start Date

Jun 30, 1999

Tenure

17.93

Tenure Rank

1.8%

Managing director and portfolio manager of Jennison Associates LLC since 1999. He has a BA from Harvard University and an MBA from Columbia University. Mr. Chan generally has final authority over all aspects of the portfolio’s investments, including but not limited to, purchases and sales of individual securities, portfolio construction, risk assessment, and management of cash flows.


Debra Netschert

Manager

Start Date

Jan 28, 2015

Tenure

2.34

Tenure Rank

17.4%

Debra Netschert is a Managing Director of Jennison. Ms. Netschert joined Jennison Associates in January 2008. Prior to Jennison, Ms. Netschert held health care research analyst positions at Magnetar Capital, Amaranth Capital, Lazard Capital Markets and UBS. She received her BS and MS from Boston University.


Tenure Analysis

Category Low

0.3

Category High

19.7

Category Average

9.02

Category Mode

0.3